메뉴 건너뛰기




Volumn 29, Issue 8, 2014, Pages 1525-1532

FGF23 protein expression in coronary arteries is associated with impaired kidney function

Author keywords

Arteriosclerosis; Immunohistochemistry; Kidney

Indexed keywords

DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; KLOTHO PROTEIN;

EID: 84899680442     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft523     Document Type: Article
Times cited : (53)

References (29)
  • 1
    • 2142746439 scopus 로고    scopus 로고
    • FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
    • Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435
    • (2004) J Bone Miner Res , vol.19 , pp. 429-435
    • Shimada, T.1    Hasegawa, H.2    Yamazaki, Y.3
  • 2
    • 59749105862 scopus 로고    scopus 로고
    • Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis
    • Wesseling-Perry K, Pereira RC, Wang H et al. Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009; 94: 511-517
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 511-517
    • Wesseling-Perry, K.1    Pereira, R.C.2    Wang, H.3
  • 3
    • 84885226527 scopus 로고    scopus 로고
    • Plasma FGF23 levels increase rapidly after acute kidney injury
    • Christov M, Waikar SS, Pereira RC et al. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 2013; 84: 639-641
    • (2013) Kidney Int , vol.84 , pp. 639-641
    • Christov, M.1    Waikar, S.S.2    Pereira, R.C.3
  • 4
    • 33747719260 scopus 로고    scopus 로고
    • Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
    • Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91: 3144-3149
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 3144-3149
    • Antoniucci, D.M.1    Yamashita, T.2    Portale, A.A.3
  • 5
    • 84872242826 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease
    • Wan M, Smith C, Shah V et al. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease. Nephrol Dial Transplant 2013; 28: 153-161
    • (2013) Nephrol Dial Transplant , vol.28 , pp. 153-161
    • Wan, M.1    Smith, C.2    Shah, V.3
  • 6
    • 49249104701 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    • Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
    • (2008) N Engl J Med , vol.359 , pp. 584-592
    • Gutierrez, O.M.1    Mannstadt, M.2    Isakova, T.3
  • 7
    • 79958724181 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
    • Isakova T, Xie H, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439
    • (2011) JAMA , vol.305 , pp. 2432-2439
    • Isakova, T.1    Xie, H.2    Yang, W.3
  • 8
    • 79955603792 scopus 로고    scopus 로고
    • Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality
    • Wolf M, Molnar MZ, Amaral AP et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol 2011; 22: 956-966
    • (2011) J Am Soc Nephrol , vol.22 , pp. 956-966
    • Wolf, M.1    Molnar, M.Z.2    Amaral, A.P.3
  • 9
    • 0344945402 scopus 로고    scopus 로고
    • Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
    • Larsson T, Nisbeth U, Ljunggren O et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003; 64: 2272-2279
    • (2003) Kidney Int , vol.64 , pp. 2272-2279
    • Larsson, T.1    Nisbeth, U.2    Ljunggren, O.3
  • 10
    • 80555148939 scopus 로고    scopus 로고
    • FGF23 induces left ventricular hypertrophy
    • Faul C, Amaral AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408
    • (2011) J Clin Invest , vol.121 , pp. 4393-4408
    • Faul, C.1    Amaral, A.P.2    Oskouei, B.3
  • 11
    • 9344242932 scopus 로고    scopus 로고
    • Coronary artery calcification in patients with CRF not undergoing dialysis
    • Russo D, Palmiero G, De Blasio AP et al. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004; 44: 1024-1030
    • (2004) Am J Kidney Dis , vol.44 , pp. 1024-1030
    • Russo, D.1    Palmiero, G.2    De Blasio, A.P.3
  • 12
    • 3543139492 scopus 로고    scopus 로고
    • Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
    • Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2208-2218
    • Block, G.A.1    Klassen, P.S.2    Lazarus, J.M.3
  • 13
    • 0037337818 scopus 로고    scopus 로고
    • Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels
    • Moe SM, Duan D, Doehle BP et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63: 1003-1011
    • (2003) Kidney Int , vol.63 , pp. 1003-1011
    • Moe, S.M.1    Duan, D.2    Doehle, B.P.3
  • 14
    • 34248512085 scopus 로고    scopus 로고
    • Mineralized tissue cells are a principal source of FGF23
    • Yoshiko Y, Wang H, Minamizaki T et al. Mineralized tissue cells are a principal source of FGF23. Bone 2007; 40: 1565-1573
    • (2007) Bone , vol.40 , pp. 1565-1573
    • Yoshiko, Y.1    Wang, H.2    Minamizaki, T.3
  • 15
  • 16
    • 77951726222 scopus 로고    scopus 로고
    • Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma
    • Voigt M, Fischer DC, Rimpau M et al. Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. Histopathology 2010; 56: 775-788
    • (2010) Histopathology , vol.56 , pp. 775-788
    • Voigt, M.1    Fischer, D.C.2    Rimpau, M.3
  • 17
    • 70350223807 scopus 로고    scopus 로고
    • Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
    • Pereira RC, Jüppner H, Azucena-Serrano CE et al. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 2009; 45: 1161-1168
    • (2009) Bone , vol.45 , pp. 1161-1168
    • Pereira, R.C.1    Jüppner, H.2    Azucena-Serrano, C.E.3
  • 18
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method
    • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
    • (2001) Methods , vol.25 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 19
    • 79957870135 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
    • Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1380
    • (2011) Kidney Int , vol.79 , pp. 1370-1380
    • Isakova, T.1    Wahl, P.2    Vargas, G.S.3
  • 20
    • 84857069906 scopus 로고    scopus 로고
    • Early skeletal and biochemical alterations in pediatric chronic kidney disease
    • Wesseling-Perry K, Pereira RC, Tseng CH et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2012; 7: 146-152
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 146-152
    • Wesseling-Perry, K.1    Pereira, R.C.2    Tseng, C.H.3
  • 21
    • 77957606585 scopus 로고    scopus 로고
    • Phosphorus and coronary calcification in predialysis patients
    • Russo D, Battaglia Y, Buonanno E. Phosphorus and coronary calcification in predialysis patients. Kidney Int 2010; 78: 818
    • (2010) Kidney Int , vol.78 , pp. 818
    • Russo, D.1    Battaglia, Y.2    Buonanno, E.3
  • 22
    • 14544308827 scopus 로고    scopus 로고
    • Mechanisms of vascular calcification in renal disease
    • Shanahan CM. Mechanisms of vascular calcification in renal disease. Clin Nephrol 2005; 63: 146-157
    • (2005) Clin Nephrol , vol.63 , pp. 146-157
    • Shanahan, C.M.1
  • 23
    • 84882238083 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
    • Scialla JJ, Lau WL, Reilly MP et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 2013; 83: 1159-1168
    • (2013) Kidney Int , vol.83 , pp. 1159-1168
    • Scialla, J.J.1    Lau, W.L.2    Reilly, M.P.3
  • 24
    • 44449118964 scopus 로고    scopus 로고
    • Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro
    • Wang H, Yoshiko Y, Yamamoto R et al. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 2008; 23: 939-948
    • (2008) J Bone Miner Res , vol.23 , pp. 939-948
    • Wang, H.1    Yoshiko, Y.2    Yamamoto, R.3
  • 26
    • 78651408919 scopus 로고    scopus 로고
    • Klotho deficiency causes vascular calcification in chronic kidney disease
    • Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136
    • (2011) J Am Soc Nephrol , vol.22 , pp. 124-136
    • Hu, M.C.1    Shi, M.2    Zhang, J.3
  • 27
    • 84860778116 scopus 로고    scopus 로고
    • Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23
    • Lim K, Lu TS, Molostvov G et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23. Circulation 2012; 125: 2243-2255
    • (2012) Circulation , vol.125 , pp. 2243-2255
    • Lim, K.1    Lu, T.S.2    Molostvov, G.3
  • 28
    • 80052303008 scopus 로고    scopus 로고
    • Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
    • Rhee Y, Bivi N, Farrow E et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011; 49: 636-643
    • (2011) Bone , vol.49 , pp. 636-643
    • Rhee, Y.1    Bivi, N.2    Farrow, E.3
  • 29


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.